Biotest AG VZ Stock
Your prediction
Pros and Cons of Biotest AG VZ in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Biotest AG VZ vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Biotest AG VZ | - | - | - | - | - | - | - |
| MPH Health Care AG | -1.350% | -2.667% | 2.336% | -2.232% | -2.232% | 44.554% | -3.947% |
| Rockwell Medical Inc. | -6.560% | 2.622% | -15.123% | -64.087% | -64.087% | -23.789% | -91.106% |
| Pacira Pharmaceuticals | -1.820% | 1.852% | 10.000% | 18.919% | 18.919% | -38.547% | -53.586% |
News
EQS-News: Biotest announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt)
EQS-News: Biotest announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt)
EQS-News: Biotest obtains approval for new human fibrinogen Prufibry® in Germany
EQS-News: Biotest obtains approval for new human fibrinogen Prufibry® in Germany
EQS-News: Biotest AG: Extraordinary general meeting convened again at the request of Grifols S.A.
EQS-News: Biotest AG: Extraordinary general meeting convened again at the request of Grifols S.A.